Status:
COMPLETED
Viz HCM (ECG Assist) Utilization Workflow Pilot
Lead Sponsor:
Viz.ai, Inc.
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, open-label, multi-center workflow pilot. Viz HCM will be implemented at each participating site and all conforming incoming ECG recordings within a 6-month enrollment period wil...
Detailed Description
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that causes the walls of the lower heart chambers to thicken and stiffen. As the disease progresses, thickened walls around the left vent...
Eligibility Criteria
Inclusion
- Patients aged 18 years of greater at the time of arrival to healthcare facility
- Patients underwent resting 12-lead digital electrocardiogram (ECG) at healthcare facility
Exclusion
- Patients with poor or incomplete recordings
Key Trial Info
Start Date :
January 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT06600256
Start Date
January 10 2022
End Date
June 30 2024
Last Update
September 19 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
UC San Diego Sulpizio Cardiovascular Center
La Jolla, California, United States, 92037
2
The Valley Hospital
Ridgewood, New Jersey, United States, 07450
3
The Mount Sinai Hospital
New York, New York, United States, 10029
4
Centennial Heart Cardiovascular Consultants
Nashville, Tennessee, United States, 37203